Table III.
IL6, occludin and TNF-α levels in each group.
| Group | IL-6 (ng/l) | Occludin (ng/l) | TNF-α (ng/l) |
|---|---|---|---|
| C | 3.47±0.07 | 48.22±5.58 | 1.92±0.12 |
| M | 5.53±0.13a | 35.24±9.55a | 3.70±0.14a |
| T | 4.82±0.17b | 39.03±3.23b | 3.07±0.20b |
| G | 4.64±0.39b | 40.51±1.32b | 2.74±0.10b |
| N | 4.91±0.37b | 41.07±8.39b | 2.69±0.14b |
| L | 3.86±0.48b | 41.76±4.55b | 2.22±0.12b |
Data are reported as mean ± SD, n=10.
a
P<0.01 vs. C group
b
P<0.01 vs. M group. IL-6, interleukin-6; TNF-α, tumor necrosis factor. C, control group; M, ALD group; T, Golden Bifid treatment group; G, Glutamine treatment group; N, Medilac-S® treatment group; L, Golden Bifido and glutamine treatment group.